About Sanguine

Your committed partner for disease-state and healthy biospecimens

Our Mission

Sanguine Biosciences is accelerating discovery through manufacturing for research in therapeutics and diagnostics by finding the biospecimens needed through our direct-to-donor model. We lower the barrier for people to participate in research by donor engagement and ease in participating - often collections occurring in the donor’s home. For researchers, they receive high-quality biospecimens with comprehensive donor data.

Sanguine has been a trusted partner in translational, clinical, and cell and gene therapy research for many of the world’s leading pharmaceutical and biotechnology companies. We have helped accelerate timelines and validate early-stage results, boosting confidence in advancing to clinical trials. Now, with our disease-state LeukoCore™ and GMP-grade healthy LeukoCert™ products, we are expanding our impact into process development and manufacturing.

doctor-visiting-senior-patient-at-home

"Our study coordinators are typically on a first name basis with the patients after the first call and maintain a really close relationship with them. It's that human-to-human contact many patients enjoy that helps them feel empowered and keeps them engaged."

Brian Neman

CEO & Co-Founder of Sanguine

History of Sanguine

Image (6)

Leadership Team

brian-neman_@2x_348X348
Brian Neman, MHA  

CHIEF EXECUTIVE OFFICER

Brian brings together a deep seated belief that empowering patients is the key to advancing medicine with a strong entrepreneurial drive. The result is Sanguine.

Christine_Kelberman@2x
Christine Kelberman  

Chief Financial Officer

Chris has spent most of her finance career in the life science industry responsible for the accounting, finance, IT, financial operations, and treasury functions, including forecasting and capital planning, both stateside and internationally.

c81c8df7-a766-423b-a25b-336da968bdb4
Lisa AnnMarie Fleshman

Vice President, Quality and Compliance

AnnMarie has spent the last decade of her career devoted to quality and compliance within the pharma industry, bringing high standards and innovative thought processes along with her.

team-gerald@2x-circle-348X348-min
Gerald Lee

CHIEF PRODUCT OFFICER

Gerald has translated his experience leading a team studying Chronic Myeloid Leukemia (CML) at Stanford into the operational expertise that drives Sanguine's product development program.

Shari collins
Shari Collins  

Vice President, PRODUCT COMMERCIALIZATION & MARKETING


Life sciences commercial leader with successful records in Sales and Marketing achieving above industry average revenue growth and attuned to customer needs across academia, government, and pharma.

Join Sanguine

Help us accelerate the pace of discovery and development by bridging the gap between patients and researchers.